The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Azilsartan medoxomil · AZILSARTAN KAMEDOXOMIL 40 mg/1 · Tablet · Oral · Lupin Pharmaceuticals, Inc.
NDC 70748-0236-06 · 30 TABLET in 1 BOTTLE · ANDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | PC | Dec 12, 2026 |
| exclusivity | PC | Dec 12, 2026 |
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Lupin Pharmaceuticals, Inc. | AZILSARTAN KAMEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals, Inc. | AZILSARTAN KAMEDOXOMIL 80 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Ireland Limited | AZILSARTAN MEDOXOMIL 40 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Takeda Ireland Limited | AZILSARTAN MEDOXOMIL 80 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Azilsartan medoxomil — NDC 70748-0236-06," retrieved September 3, 2026, https://drugdashboards.com/drug/70748023606.
Free to cite with attribution — see how the data is put together.